Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Boyer

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Chest|January 23, 1998
New chemotherapeutic agents in the treatment of non-small cell lung cancer: the Australian experienceM J Boyer
Oncology Research|January 1, 1997
Bioreductive agents: a clinical updateM J Boyer
NLN Publications|February 1, 1995
Leadership and collaboration: sharing of powerM J Boyer
NLN Publications|March 1, 1993
Partnership for change: improving the medication experienceM J Boyer, C Lillis
Gene Therapy|November 9, 2007
The CDK inhibitors: potential targets for therapeutic stem cell manipulations?M J Boyer, T Cheng
Methods in Cell Biology|January 1, 1994
Measurement of intracellular pHM J Boyer, D W Hedley
Sabouraudia|December 1, 1983
The use of Histolyn CYL in an enzyme immunoassay to detect Histoplasma capsulatum antibodiesM J Boyer, G M Scalarone
Medical and Pediatric Oncology|January 1, 1990
Diethylstilbestrol revisited in advanced breast cancer managementM J Boyer, M H Tattersall
Infection and Immunity|January 1, 1989
Lipid-modified surface protein antigens expressing size variation within the species Mycoplasma hyorhinisM J Boyer, K S Wise
Cancer Research|August 15, 1992
Regulation of intracellular pH in tumor cell lines: influence of microenvironmental conditionsM J Boyer, I F Tannock
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Chest|January 23, 1998
New chemotherapeutic agents in the treatment of non-small cell lung cancer: the Australian experienceM J Boyer
Oncology Research|January 1, 1997
Bioreductive agents: a clinical updateM J Boyer
NLN Publications|February 1, 1995
Leadership and collaboration: sharing of powerM J Boyer
NLN Publications|March 1, 1993
Partnership for change: improving the medication experienceM J Boyer, C Lillis
Gene Therapy|November 9, 2007
The CDK inhibitors: potential targets for therapeutic stem cell manipulations?M J Boyer, T Cheng
Methods in Cell Biology|January 1, 1994
Measurement of intracellular pHM J Boyer, D W Hedley
Sabouraudia|December 1, 1983
The use of Histolyn CYL in an enzyme immunoassay to detect Histoplasma capsulatum antibodiesM J Boyer, G M Scalarone
Medical and Pediatric Oncology|January 1, 1990
Diethylstilbestrol revisited in advanced breast cancer managementM J Boyer, M H Tattersall
Infection and Immunity|January 1, 1989
Lipid-modified surface protein antigens expressing size variation within the species Mycoplasma hyorhinisM J Boyer, K S Wise
Cancer Research|August 15, 1992
Regulation of intracellular pH in tumor cell lines: influence of microenvironmental conditionsM J Boyer, I F Tannock
Pageof 6